Aeluma, Inc. Form 8-K Summary
Business Context and Reporting Period
Aeluma, Inc. filed a Current Report on Form 8-K regarding the third closing of a private equity offering. The report identifies April 3, 2023 as the date of the earliest reported event and was signed on April 5, 2023. The filing does not provide operating or period-end financial results.
Transaction and Key Financial Metrics
- The offering was conducted pursuant to subscription agreements with accredited investors at $3.00 per common share.
- The filing states that the initial closing issued an aggregate of “517,0000” shares for gross proceeds of $1,551,000. The apparent share count is unclear in the filing text; the proceeds imply 517,000 shares at $3.00 per share.
- The second closing on January 10, 2023 issued 214,667 shares for gross proceeds of $644,000.
- The third closing on March 31, 2023 issued 715,666 shares for gross proceeds of $2,147,000.
- Total gross proceeds from the offering to date were reported as $4,342,000.
- For the third closing, the company paid a cash placement-agent fee of $117,760.10 and agreed to issue warrants to purchase up to 6,720 shares at an exercise price of $3.00 per share.
- The filing provides no revenue, profit, cash-flow, margin, debt, liquidity, or cash-balance information.
Material Changes, Outlook, and Risks
- The material change was the completion of the third offering closing and the associated receipt of approximately $2.147 million in gross proceeds.
- The offering securities were sold without registration under the Securities Act, in reliance on Section 4(a)(2) and Rule 506 of Regulation D, based in part on investor representations.
- The company agreed to register the shares issued in the offering, including shares underlying the placement-agent warrant, under a registration rights agreement.
- The securities may not be offered or sold in the United States absent registration or an applicable exemption. The filing states that the transaction was not a public offering and involved no general solicitation or advertising.
- The subscription agreement includes customary representations, warranties, indemnification obligations, termination provisions, and other contractual rights and obligations.
- No management guidance, business outlook, use of proceeds, contingencies beyond the transaction terms, or operating risks were disclosed in the provided filing text.
Investor Verification Items
- Verify the initial closing share count, because the filing text reports “517,0000,” while the stated proceeds and price imply 517,000 shares.
- Confirm the final aggregate number of shares issued and the resulting dilution, including the 6,720 placement-agent warrant shares.
- Review the full subscription agreement, registration rights agreement, and placement-agent warrant terms incorporated by reference from the December 23, 2022 Form 8-K.
- Assess the company’s subsequent registration of the resale shares and any related selling-stockholder activity.
- Review later SEC filings for the use of proceeds, cash runway, operating results, and any additional financing.